Aspirin is one of the most extensively studied drugs in history, with a 110-year track record of efficacy and safety. More than 200,000 patients have been studied in more than 200 randomized clinical trials evaluating aspirin efficacy and safety across a range of doses. When taken regularly, aspirin has been shown to significantly reduce the risk of heart attack and recurrent stroke. However, despite its well-established benefits, including support from guidelines recommendations by AHA, USPSTF, American Diabetes Association, World Health Organization and other health organizations, aspirin is widely underutilized in the United States and the world over. Reports show aspirin is used by only about half of those who should be using it to prevent CV events.
Bayer is committed to improving public health by promoting the safe and appropriate use of aspirin for CV event prevention. In addition to supporting numerous scientific studies in cardiovascular disease, Bayer has meaningful partnerships with many organizations, including AHA, PFP, WomenHeart: The National Coalition for Women with Heart Disease, and the National Stroke Association, to help raise awareness of the risks of CVD and ways to help control risk factors, including increasing the appropriate use of aspirin therapy.
About Bayer Consumer Care
The Consumer Care Division of Bayer HealthCare LLC, is headquartered in
Morristown, N.J. Bayer's Consumer Care Division is among the largest
marketers of over-the-counter medications and nutritional supplements in
the world. Some of the most trusted and recognizable brands in the world
today come from the Bayer portfolio of products. These include Bayer(R)
Aspirin, ALEVE(R), Flanax(R)/Apronax(R), Alka-Seltzer Plus(R), Bactine(R),
RID(R), Phillips'(R) Milk of Magnesia, Midol(R), Alka-Seltzer(R),
Talcid(R), Rennie(R), Canesten(R), Bepanthen(R), Bepanthol(R), One A Day(R)
vitamins, Flintstones(T
'/>"/>
| SOURCE Bayer Consumer Care Copyright©2008 PR Newswire. All rights reserved |